home / stock / pjt / pjt news


PJT News and Press, PJT Partners Inc. Class A From 03/26/24

Stock Information

Company Name: PJT Partners Inc. Class A
Stock Symbol: PJT
Market: NYSE
Website: pjtpartners.com

Menu

PJT PJT Quote PJT Short PJT News PJT Articles PJT Message Board
Get PJT Alerts

News, Short Squeeze, Breakout and More Instantly...

PJT - PJT Partners cut to Sell as UBS sees limited earnings growth

2024-03-26 12:16:24 ET More on PJT Partners PJT Partners: Early In The Wave PJT Partners Inc. (PJT) Q4 2023 Earnings Call Transcript PJT Partners Q4 2023 Earnings Preview Goldman turns bearish on Perella Weinberg Partners, neutral on PJT Partners Seek...

PJT - Pluri's Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report

International Coffee Organization (ICO) Market Report published o n March 7, 2024 highlights alarming price instability challenging the coffee industry According to the report, adverse weather conditions, first noted in 2022 an...

PJT - Engage with Pluri's Talent: Exciting Conference Appearances Ahead

HAIFA, Israel, March 19, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company"), a leading biotechnology company that transforms cells into solutions that promote global wellbeing and sustainability, today announced its participation in the following upcoming con...

PJT - Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing

HAIFA, Israel, March 14, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company"), a leading biotechnology company that transforms cells into solutions, today announced that its CDMO division (PluriCDMO™) has signed a manufacturing agreement with Remedy Cell...

PJT - Pluri(TM) Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation

HAIFA, Israel, March 11, 2024 (GLOBE NEWSWIRE) -- In a strategic move that underscores its innovative edge in the agtech sector, Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company") today announced an important expansion to its intellectual property portfolio with a new patent approval...

PJT - Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board

HAIFA, Israel, March 06, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), a leading biotech company that transforms cells into solutions that promote global wellbeing and sustainability, today announced the appointment of atto...

PJT - Pluri's Innovation Across Various Industries: CEO Updates on Recent Achievements & 2024 Goals

Growing pipeline of industry-specific new potential products, services, collaborations and partnerships through PluriAg t ech , PluriCDMO , PluriHealth , and PluriFood Recent achieve ments include: new cell-based coffee business; ...

PJT - PJT Partners: Early In The Wave

2024-02-21 16:50:09 ET Summary PJT Partners is a leader in restructuring, driving their overall growth with robust mandates. Other companies like Moelis are also posting good quarters from restructuring, but PJT got started earlier. Park Hill, the placement business, is strugg...

PJT - PJT Partners Inc. (PJT) Q4 2023 Earnings Call Transcript

2024-02-06 15:11:10 ET PJT Partners Inc. (PJT) Q4 2023 Earnings Conference Call February 06, 2024, 08:30 AM ET Company Participants Sharon Pearson - Head, IR Paul Taubman - Chairman and CEO Helen Meates - CFO Conference Call Participants Devin Ryan - ...

PJT - PJT Partners Non-GAAP EPS of $0.96 beats by $0.08, revenue of $329M beats by $24.74M

2024-02-06 06:52:05 ET More on PJT Partners Goldman turns bearish on Perella Weinberg Partners, neutral on PJT Partners Seeking Alpha’s Quant Rating on PJT Partners Historical earnings data for PJT Partners Dividend scorecard for PJT Partners ...

Previous 10 Next 10